Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Harmony Biosciences Holdings Inc shares valued at $755,434 were purchased by SANDIP KAPADIA on Jan 15 ’26. At $36.04 per share, SANDIP KAPADIA acquired 20,961 shares.
Also, Dayno Jeffrey M. sold 25,933 shares, netting a total of over 1,040,103 in proceeds. Following the sale of shares at $40.11 each, the insider now holds 0 shares.
Before that, JEFFREY M DAYNO had added 25,933 shares to its account. In a trade valued at $1,026,687, the Director bought Harmony Biosciences Holdings Inc shares for $39.59 each.
As published in their initiating research note from Truist on July 21, 2025, Harmony Biosciences Holdings Inc [HRMY] has been a Buy and the price target has been revised to $48. Earlier on February 11, 2025, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for HRMY stock.
Analyzing HRMY Stock Performance
On last trading session, Harmony Biosciences Holdings Inc [NASDAQ: HRMY] rose 1.03% to $36.41. The stock’s lowest price that day was $35.75, but it reached a high of $36.69 in the same session. During the last five days, there has been a drop of approximately -3.86%. Over the course of the year, Harmony Biosciences Holdings Inc shares have dropped approximately -0.03%.
Support And Resistance Levels for Harmony Biosciences Holdings Inc (HRMY)
RSI (Relative Strength Index) is 45.31 on the 14-day chart, showing neutral technical sentiment.
Is Harmony Biosciences Holdings Inc subject to short interest?
Stocks of Harmony Biosciences Holdings Inc saw a sharp steep in short interest on 2025-12-31 dropping by 58659.0 shares to 4.35 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 4.41 million shares. A decline of -1.35% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.43 of the overall float, the days-to-cover ratio (short ratio) decline to 6.43.
Which companies own the most shares of Harmony Biosciences Holdings Inc (HRMY)?
In terms of Harmony Biosciences Holdings Inc share price expectations, FactSet research, analysts set an average price target of 46 in the next 12 months, up nearly 27.64% from the previous closing price of $36.04. Analysts anticipate Harmony Biosciences Holdings Inc stock to reach 62 by 2026, with the lowest price target being 43. In spite of this, 6 analysts ranked Harmony Biosciences Holdings Inc stock as Buy at the end of 2026. On December 17, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $75.
